Larry Smith is doing a point by point critique follow up to the Feurstein article . This should be interesting as Mr. Smith has a large group of followers and subscribers to his reports and is well respected in biotech research reporting. He also has a very good track record. Should be out early next week!
Great, we'll hear about the positives and negatives instead of just the negatives.
Does anybody know of another cancer treatment that (a) may work for all solid cancers, (b) may double the OS at least, (c) has virtually no toxicity, (d) works for everybody (no biomarker screening necessary), (e) is easy to administer at both the front and back end, (f) has low COGS and (g) Europe (and possibly the FDA as well) are wild about?